Bahiana broadcasts RUTE's first videoconference at SIG Telepsychiatry

CLICK HERE to view the event poster.

This Friday (August 20th), from 10 am to 12 pm, the Bahiana, through CEDETE - Center for the Development of Educational Technologies, will transmit for the first time a videoconference in the SIG (Special Interest Group) of Telepsychiatry, to teaching and research institutions linked to RUTE - RNP's Telemedicine University Network - National Network of research. With the theme Pharmacological Management of Associated Symptoms in Patients with Pervasive Developmental Disorder, the lecture will be given by Prof. Drª Milena Pondé. Professor of Psychiatry and Psychopharmacology at Bahiana, she holds a Ph.D. in Public Health with a Post-Doctorate in the Division of Social and Cultural Psychiatry at McGill University, Montreal-Canada. Check out an interview with Dr. Milena Pondé below.

The videoconference will be transmitted in the CEDETE room, located in the Coordination of the Bahiana – Av. Don João VI, 275, Brotas. Enrollments can be made in the Virtual Learning Environment – ​​AVA. The conference will be filmed and made available later on the AVA's video bank, in the category open to the community. 

1 - This is the first time that the Bahiana broadcasts a conference call from RUTE's Telepsychiatry SIG. How do you feel about participating in this initiative and what is the importance of an activity like this for the Bahiana?

The SIG has allowed a dialogue between researchers from different specialties in the field of psychiatry, with current themes, discussed in depth. THE Bahiana has participated in discussions with students of the psychiatry course, which has been very enriching for both the student body and the faculty.

2 - Bahiana, through CEDETE, has it been fulfilling its role in RUTE? How are we being seen by other institutions in the Network?

Bahiana has an active participation, with state-of-the-art technology, which allows us an excellent connection with the network.

3 - In your lecture, you will talk about: "Autism: Pharmacological management". In a few lines, what will the audience be able to learn from this meeting? What will be the main points covered?

In which situations the pharmacological approach is indicated and which measurements are available.
As the title suggests, I will talk about the possibilities of pharmacological approaches to symptoms associated with autism, such as hyperactivity, aggression, insomnia, psychomotor agitation, and impulsivity. We know that autism is a developmental disorder that requires a multidisciplinary approach, especially psychopedagogical, the class approach, however, will focus on the psychopharmacological aspect.

4 - Is the use of drugs to treat these disorders a constant?

No, only when there are associated behavioral symptoms.

5 - Are there cases in which the use of medication cannot be dispensed with?

Yes, cases with associated aggressiveness.

6 - Combined with therapy, can medications achieve better performance?

The main therapy for autistic children is psychoeducation, drug therapy is supporting, helping the child to have better access to psychoeducation.